Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Siezenga, Machiel A ^a   Chandie Shaw, Prataap K ^b   Daha, Mohamed R ^a   Rabelink, Ton J ^a   Berger, Stefan P ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; Mannose Binding Lectin (MBL); South Asians; Type 2 diabetes

Indexed keywords

MANNOSE BINDING LECTIN; COMPLEMENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; SOUTH ASIA; BLOOD; CORONARY ARTERY BYPASS GRAFT; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; INCIDENCE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; SOUTHEAST ASIA; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; ANGIOPLASTY, BALLOON, CORONARY; ASIA, SOUTHEASTERN; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMPLEMENT SYSTEM PROTEINS; CORONARY ARTERY BYPASS; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES;

EID: 79959832951     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-60     Document Type: Article

References (31)

1. Anand SS, Yusuf S. Risk factors for cardiovascular disease in Canadians of South Asian and European origin: a pilot study of the Study of Heart Assessment and Risk in Ethnic Groups (SHARE). Clin Invest Med 1997, 20:204-210.
2. Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in South Asians compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 2006, 49:2580-2588. 10.1007/s00125-006-0393-2, 16972045.
3. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999, (340):115-126.
4. Ostergaard J, Hansen TK, Thiel S, Flyvbjerg A. Complement activation and diabetic vascular complications. Clin Chim Acta 2005, 361:10-19. 10.1016/j.cccn.2005.04.028, 15996650.
5. Rus HG, Niculescu F, Vlaicu R. Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls. Immunol Lett 1988, 19:27-32. 10.1016/0165-2478(88)90115-0, 3192278.
6. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol 2006, 18:16-23. 10.1016/j.coi.2005.11.014, 16368230.
7. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006, 7:85-94. 10.1038/sj.gene.6364283, 16395391.
8. Saevarsdottir S, Oskarsson OO, Aspelund T, Eiriksdottir G, Vikingsdottir T, Gudnason V, Valdimarsson H. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 2005, 201:117-125. 10.1084/jem.20041431, 2212774, 15623574.
9. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The Concentration of the C-Type Lectin, Mannan-Binding Protein, in Human Plasma Increases During An Acute Phase Response. Clin Exp Immunol 1992, 90:31-35. 1554537, 1395098.
10. Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 2004, 53:1570-1576. 10.2337/diabetes.53.6.1570, 15161763.
11. Hansen TK, Gall MA, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A. Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med 2006, 166:2007-2013. 10.1001/archinte.166.18.2007, 17030835.
12. Best LG, Davidson M, North KE, MacCluer JW, Zhang Y, Lee ET, Howard BV, DeCroo S, Ferrell RE. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation 2004, 109:471-475. 10.1161/01.CIR.0000109757.95461.10, 14732744.
13. Chandie Shaw PK, van Es LA, Paul LC, Rosendaal FR, Souverijn JH, Vandenbroucke JP. Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy. Diabetologia 2003, 46:618-624.
14. Siezenga MA, Chandie Shaw PK, van der Geest RN, Mollness TE, Daha MR, Rabelink TJ, Berger SP. Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians. Clin Exp Immunol 2009, 157:98-103. 10.1111/j.1365-2249.2009.03959.x, 2710597, 19659775.
15. Roos A, Dieltjes P, Vossen RH, Daha MR, de Knijff P. Detection of three single nucleotide polymorphisms in the gene encoding mannose-binding lectin in a single pyrosequencing reaction. J Immunol Methods 2006, 309:108-114. 10.1016/j.jim.2005.11.017, 16410008.
16. Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005, 5:1361-1366. 10.1111/j.1600-6143.2005.00841.x, 15888042.
17. Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, Bouwman LH, Schlagwein N, Fallaux van der HF, Faber-Krol MC, Madsen HO, Schwaeble WJ, Matsushita M, Fujita T, Daha MR. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004, 34(9):2589-2598. 10.1002/eji.200324401, 15307191.
18. Prasad GV, Vangala SK, Silver SA, Wong SC, Huang M, Rapi L, Nash MM, Zaltzman JS. South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantation. Clin J Am Soc Nephrol 2011, 6(1):204-2011. 10.2215/CJN.03100410, 20884776.
19. Fischbacher CM, Bhopal R, Povey C, Steiner M, Chalmers J, Mueller G, Jamieson J, Knowles D. Record linked retrospective cohort study of 4.6 million people exploring ethnic variations in disease: myocardial infarction in SOuth Asians. BMC Public Health 2007, 7:142. 10.1186/1471-2458-7-142, 1965474, 17615055.
20. Nijjar AP, Wang H, Dasgupta K, Rabi DM, Quan H, Khan NA. Outcomes in a diabetic population of South Asians and whites following hospitalization for acute myocardial infarction: a retrospective cohort study. Cardiovasc Diabetol 2010, 22(9):4-11.
21. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet 1998, 352:959-960. 10.1016/S0140-6736(05)61513-9, 9752823.
22. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding-lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004, 351(5):260-267.
23. Keller TT, van Leuven SI, Meuwese MC, Wareham NJ, Luben R, Stroes ES, Hack E, Levi M, Khaw KT, Boekholdt SM. Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol 2006, 26:2345-2350. 10.1161/01.ATV.0000240517.69201.77, 16902159.
24. Best LG, Ferrell RE, DeCroo S, North KE, MacCluer JW, Zhang Y, Lee ET, Howard BV, Umans J, Palmieri V, Garred P. Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study. BMC Med Genet 2009, 10(5).
25. Tertov VV, Sobenin IA, Tonevitsky AG, Orekhov AN, Smirnov VN. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun 1990, 167:1122-1127. 10.1016/0006-291X(90)90639-5, 2322261.
26. Alipour A, van Oostrom AJHHM, van Wijk JPH, Verseyden C, PLokker HWM, Jukema JW, Rabelink AJ, Castro Cabezas M. Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects. Atherosclerosis 2009, 206:444-450. 10.1016/j.atherosclerosis.2009.03.007, 19380135.
27. Rugonfalvi-Kiss S, Endrész V, Madsen HO, Burian K, Duba J, Prohaszka Z, Karadi I, Romics L, Gönczöl E, Füst G, Garred P. Association of Chlamydia pneumonia with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 2002, 106:1071-1076. 10.1161/01.CIR.0000027137.96791.6A, 12196331.
28. Walsh MC, Bourcier T, Takahashi K, Shi L, Busche MN, Rother RP, Solomon SC, Ezekowitz AB, Stahl GL. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005, 175:541-546.
29. Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 2001, 159:1045-1054. 10.1016/S0002-9440(10)61779-8, 1850443, 11549596.
30. Matthijsen RA, de Winther MPJ, Kuipers D, van der Made I, Weber C, Herias V, Gijbels MJJ, Buurman WA. Macrophage-specific expression of Mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009, 119:2188-2195. 10.1161/CIRCULATIONAHA.108.830661, 19380618.
31. Garred P, Flemming L, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003, 40:73-84. 10.1016/S0161-5890(03)00104-4, 12914814.